β-<4-(2-Aminoethyl)-phenyl>-propionsaeure | 61629-97-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: β-<4-(2-Aminoethyl)-phenyl>-propionsaeure
• 英文别名: 3-<4-(2-Amino-ethyl)-phenyl>-propionsaeure；3-(4-(2-Aminoethyl)phenyl)propanoic acid；3-[4-(2-aminoethyl)phenyl]propanoic acid
• CAS: 61629-97-8
• 化学式: C₁₁H₁₅NO₂
• 分子量: 193.246
• InChiKey: WRDNEIWSNLKAMD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.3
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1R,2S,3R,4S)-4-(6-amino-2-chloropurin-9-yl)-N-ethyl-2,3-dihydroxycyclopentane-1-carboxamide 、 β-<4-(2-Aminoethyl)-phenyl>-propionsaeure 生成 3-[4-[2-[[6-amino-9-[(1S,2R,3S,4R)-4-(ethylcarbamoyl)-2,3-dihydroxycyclopentyl]purin-2-yl]amino]ethyl]phenyl]propanoic acid
  参考文献：
  名称：

  CHEN, JEN;GRIM, MICHAEL;ROCK, CAREN;CHAN, KENNETH, TETRAHEDRON LETT., 30,(1989) N1, C. 5543-5546

  摘要：

  DOI：
• 作为产物：
  描述：

  N-(2-苯乙基)乙酰胺 生成 β-<4-(2-Aminoethyl)-phenyl>-propionsaeure
  参考文献：
  名称：

  DD124974

  摘要：

  公开号：

文献信息

• [EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR LE TRAITEMENT DU VIRUS RESPIRATOIRE SYNCYTIAL
  申请人：CIDARA THERAPEUTICS INC

  公开号：WO2020252396A1

  公开（公告）日：2020-12-17

  Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral RSV F protein (e.g., Presatovir, MDT 637, JNJ 179, or an analog thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., RSV infections).

  用于治疗病毒感染的组合物和方法包括含有病毒RSV F蛋白抑制剂（例如Presatovir、MDT 637、JNJ 179或其类似物）的共轭物，连接到一个Fc单体、一个Fc结构域和Fc结合肽、一种白蛋白蛋白质或白蛋白结合肽。特别是，这些共轭物可以用于治疗病毒感染（例如RSV感染）。
• Novel Indoline Compounds
  申请人：LEBRETON Luc

  公开号：US20080119465A1

  公开（公告）日：2008-05-22

  Sulfonylindoline compounds of formula I, wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.

  公式I的磺胺基吲哚化合物，其中R1至R4，Y和Z具有定义的含义，一种制备这种化合物的过程，以及用作药用活性物质，特别用于治疗或抑制神经退行性疾病、心血管疾病、炎症性疾病、高胆固醇血症、血脂异常、肥胖或糖尿病。
• [EN] 2,6-DIAMINOPURINE DERIVATIVES<br/>[FR] DERIVES DE LA 2,6-DIAMINOPURINE
  申请人：GLAXO GROUP LIMITED

  公开号：WO1994017090A1

  公开（公告）日：1994-08-04

  (EN) 2,6-Diaminopurine-$g(b)-D-ribofuranuronamide derivatives are described having general formula (I) and salts and solvates thereof, wherein: R1 is hydrogen, C3-8cycloalkyl or C1-6alkyl; R2 is C3-8cycloalkyl, C3-8cycloalkylC1-6alkyl, Alk1Y, -(CHR5)m(Alk2)nZ or appropriately substituted C3-8cycloalkyl, C3-8cycloalkylC1-6alkyl, pyrrolidin-3-yl, 2-oxopyrrolidin-4-yl, 2-oxopyrrolidin-5-yl, piperidin-3-yl or piperidin-4-yl, and Q is oxygen or sulphur. Compounds of formula (I) and their salts and solvates have use in medicine as anti-inflammatory agents, particularly in the treatment of patients with inflammatory conditions who are susceptible to leukocyte-induced tissue damage.(FR) On décrit des dérivés du 2,6-diaminopurine-$g(b)-D-ribofuranuronamide ayant la formule générale (I) ainsi que leurs sels et solvates. Dans cette formule: R1 est un hydrogène, un C3-8cycloalkyle ou un C1-6alkyle; R2 est un C3-8cycloalkyle, un C3-8cycloalkylC1-6alkyle, un Alk1Y, un -(CHR5)m(Alk2)nZ ou un des groupes suivants, portant des substituants appropriés: C3-8cycloalkyle, C3-8cycloalkylC1-6alkyle, pyrrolidin-3-yle, 2-oxopyrrolidin-4-yle, 2-oxopyrrolidin-5-yle, pipéridin-3-yle ou pipéridin-4-yle, et Q est oxygène ou le soufre. Les composés de la formule (I) et leurs sels et solvates sont utiles en médecine comme agents anti-inflammatoires, en particulier pour le traitement de patients souffrant d'affections inflammatoires avec risques de lésions tissulaires, induites par les leucocytes.

  描述了具有通式(I)及其盐和溶剂化物的2,6-二氨基嘌呤-$g(b)-D-核糖尿苷衍生物，其中：R1为氢、C3-8环烷基或C1-6烷基；R2为C3-8环烷基、C3-8环烷基C1-6烷基、Alk1Y、-(CHR5)m(Alk2)nZ或适当取代的C3-8环烷基、C3-8环烷基C1-6烷基、吡咯烷-3-基、2-氧代吡咯烷-4-基、2-氧代吡咯烷-5-基、哌啶-3-基或哌啶-4-基，Q为氧或硫。通式(I)化合物及其盐和溶剂化物在医学上具有抗炎作用，特别是用于治疗易受白细胞诱导的组织损伤的炎症病患。
• Polyphenylene ether resin composition
  申请人：MITSUBISHI GAS CHEMICAL COMPANY, INC.

  公开号：EP0131445A2

  公开（公告）日：1985-01-16

  @ A polyphenylene ether resin composition comprising (A) a polyphenylene ether resin, and (B) an aromatic polyamide having a melting point of up to 330°C composed mainly of at least one kind of recurring structural units containing an aromatic nucleus represented for formula (I) wherein R' represents an alkylenephenylene or dialkylenephenylene group, or formula (II) wherein R2 represents a phenylene, dialkylenephenylene or biphenylene group or a group of the following formula in which X represents an alkylene group having 1 to 5 carbon atoms, an oxygen atom, a sulfur atom, a carbonyl group or a sulfonyl group, and R3 represents an alkylene group having 3 to 10 carbon atoms, a phenylene group or a naphthylene group.

  一种聚苯醚树脂组合物，包括(A)聚苯醚树脂和(B)芳香族聚酰胺，其熔点高达 330°C，主要由至少一种含有芳香族核的重复结构单元组成，如式(I)所示，其中 R'代表烷基亚苯基或二烷基亚苯基基团，或式(II)所示，其中 R2 代表亚苯基、二烷基亚苯基或联苯基团或下式基团，其中 X 代表具有 1 至 5 个碳原子的亚烷基、氧原子、硫原子、羰基或磺酰基，R3 代表具有 3 至 10 个碳原子的亚烷基、亚苯基或亚萘基。
• N9-cyclopentyl-substituted adenine derivatives
  申请人：CIBA-GEIGY AG

  公开号：EP0267878A1

  公开（公告）日：1988-05-18

  The compounds of the formula I wherein R, R3 and R5 independently represent hydrogen or hydroxy provided that at least one of R, R3 and R5 represents hydroxy; R1 represents hydrogen, lower alkyl, C3-C7alkenyl, hydroxy-lower alkyl, C3-C6cycloalkyl, C3-C6cycloalkyl-lower alkyl, 2-norbornyl, 2-norbornyl-lower alkyl, aryl, aryl-lower alkyl, aryl-C3-C6cycloalkyl, 9-fluorenyl or 9-fluorenyl-lower alkyl; or R1 represents a bicyclic benzo-fused 5 or 6-membered saturated carbocyclic radical or a benzo fused 5 or 6-membered saturated heterocyclic radical containing a heteroatom selected from oxygen and sulfur directly attached to the fused benzene ring, any said bicyclic radicals being optionally substituted on the benzo portion by lower alkyl, lower alkoxy or halogen; R2 represents hydrogen, halogen, -SR1 or -N(R9)R1 in each of which R1 has meaning as defined hereinbefore provided that R1 in -SR1 does not represent hydrogen; R9 represents hydrogen or lower alkyl; R4 represents hydroxymethyl provided that R2 does not represent either hydrogen or -NHRI in which R1 represents either hydrogen or lower alkyl; or R4 represents lower alkoxymethyl, lower alkylthiomethyl or -CONHR6 in which R6 represents lower alkyl, aryl-lower alkyl, C3-Cscycloalkyl or hydroxy-lower alkyl; pharmaceutically acceptable ester derivatives thereof in which free hydroxy groups are esterified in form of a pharmaceutically acceptable ester; and salts thereof; methods for their preparation; and their use as adenosine receptor agonists are disclosed.

  式 I 的化合物 其中R、R3和R5独立地代表氢或羟基，但R、R3和R5中至少有一个代表羟基；R1代表氢、低级烷基、C3-C7烯基、羟基-低级烷基、C3-C6环烷基、C3-C6环烷基-低级烷基、2-降冰片基、2-降冰片基-低级烷基、芳基、芳基-低级烷基、芳基-C3-C6环烷基、9-芴基或9-芴基-低级烷基；或 R1 代表双环苯并 5 或 6 元饱和碳环基，或苯并 5 或 6 元饱和杂环基，其中含有一个选自氧和硫的杂原子，直接连接到苯并环上，任何上述双环基的苯并部分可选择被低级烷基、低级烷氧基或卤素取代；R2 代表氢、卤素、-SR1 或-N(R9)R1，其中每个 R1 的含义如前文所定义，条件是 -SR1 中的 R1 不代表氢；R9 代表氢或低级烷基；R4 代表羟甲基，条件是 R2 不代表氢或-NHRI，其中 R1 代表氢或低级烷基；或R4代表低级烷氧基甲基、低级烷硫基甲基或-CONHR6，其中R6代表低级烷基、芳基-低级烷基、C3-Cscycloalkyl或羟基-低级烷基；公开了其药学上可接受的酯衍生物，其中游离羟基以药学上可接受的酯的形式酯化；及其盐；其制备方法；及其作为腺苷受体激动剂的用途。